Pl and Erythema multiforme - a phase IV clinical study of FDA data

Summary:

Erythema multiforme is reported as a side effect among people who take Pl (polypodium leucotomos), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Lamictal, and have Nasopharyngitis.

The phase IV clinical study analyzes which people have Erythema multiforme when taking Pl. It is created by eHealthMe based on reports of 640 people who have side effects when taking Pl from the FDA, and is updated regularly.

What is Pl?

Pl has active ingredients of polypodium leucotomos. eHealthMe is studying from 640 Pl users. Check the latest studies of Pl.

What is Erythema multiforme?

Erythema multiforme (a type of hypersensitivity reaction) is found to be associated with 1,705 drugs and 2,920 conditions by eHealthMe. Check the latest studies of Erythema multiforme.

On Jul, 20, 2026

640 people reported to have side effects when taking Pl.
Among them, 20 people (3.13%) have Erythema multiforme.

Among these 20 people:

How long have people been on Pl when they have Erythema multiforme? *

What is the gender of people who have Erythema multiforme when taking Pl? *

female: 66.67 %
male: 33.33 %

What is the age of people who have Erythema multiforme when taking Pl? *

What are other drugs people take besides Pl? *

What are other side effects people have besides Erythema multiforme? *

Fever: 8 people, 40.00%
Rashes (redness): 8 people, 40.00%
Drug Eruption (adverse drug reaction of the skin): 6 people, 30.00%
Appetite - Decreased (decreased appetite occurs when you have a reduced desire to eat): 5 people, 25.00%
Generalised Erythema (redness of the skin all over the body): 4 people, 20.00%
Cheilitis (infection of lips): 4 people, 20.00%
Lung Infection: 3 people, 15.00%
Nausea (feeling of having an urge to vomit): 3 people, 15.00%
Constipation: 3 people, 15.00%
Ocular Hyperaemia (an abnormally large amount of blood in eye): 3 people, 15.00%

What are the existing conditions these people have? *

Constipation: 5 people, 25.00%
Nasopharyngitis (inflammation of the nasopharynx): 5 people, 25.00%
Fever: 4 people, 20.00%
Osteoporosis (bones weak and more likely to break): 4 people, 20.00%
Insomnia (sleeplessness): 3 people, 15.00%
Lung Infection: 3 people, 15.00%
High Blood Pressure: 3 people, 15.00%
Gastritis - Chronic (long lasting inflammation of stomach): 3 people, 15.00%
Multiple Myeloma (cancer of the plasma cells): 3 people, 15.00%
Nausea (feeling of having an urge to vomit): 3 people, 15.00%

* Approximation only. Some reports may have incomplete information.

Do you take Pl and have Erythema multiforme?

- Check whether Erythema multiforme is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Pl:

Pl (640 reports)

Browse all side effects of Pl:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Erythema multiforme:

Erythema multiforme (1,705 drugs)

Browse all the conditions that are associated with Erythema multiforme:

Erythema multiforme (2,920 conditions)

Related publications that referenced our studies

Tognetti L, Giorgini S, Lotti T, "Erythema multiforme-like eruption from a slimming drug preparation cutaneous adverse drug reaction", Indian dermatology online journal, 2011 Jan .
Tognetti L, Giorgini S, Lotti T, "Erythema multiforme-like eruption from a slimming drug preparation cutaneous adverse drug reaction", Indian dermatology online journal, 2011 Jan .

How the study uses the data?

The study uses data from the FDA. It is based on polypodium leucotomos (the active ingredients of Pl) and Pl (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.